Back to search
Invasive Pneumococcal Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Invasive Pneumococcal Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Invasive Pneumococcal Disease trials you may qualify forAfter 7 then 13 valent pneumococcal conjugate vaccine (PCV) implementation in France in children, we will evaluate the impact of this vaccination on invasive pn…
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation
The study hypothesis is that a "reinforced" pneumococcal combined vaccine strategy in patients with ANCA-associated vasculitides treated with rituximab will ind…
The goal of this clinical trial is to learn if whole-cell Streptococcus pneumoniae (wSp) vaccination is safe and tolerated in healthy adults. The main aim is to…